Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LIM homeobox 9 is a developmentally expressed transcription factor containing a homeodomain and two LIM domains, enabling both DNA binding and protein-protein interactions. It plays essential roles in early gonadal development—acting with WT1 to activate Sf1, which is necessary for proper development of sexual organs. In the nervous system, LHX9 controls neuronal subtype specification and axon guidance, ensuring correct wiring of spinal pathways and defining neuronal identity in various brain regions. It is crucial for the development of the pineal gland and for maintaining normal neuroanatomy. LHX9 is highly conserved across evolution and participates in a network of transcriptional regulators coordinating organogenesis. In certain cancers, such as pediatric malignant astrocytoma and hepatocellular carcinoma, LHX9 is often epigenetically silenced, consistent with its proposed tumor suppressor function; its silencing is associated with increased cell migration and invasiveness
no drugs; for gene silencing, epigenetic regulation—hypermethylation in tumors—impacts its activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LIM homeobox 9 (LHX9).